title: [Sentinel lymph node detection in breast cancer. Experience of the Institut Curie].
abstract: Sentinel lymph node biopsy is a recently developed, minimally invasive technique for staging the axilla in breast cancer. This new procedure of selective lymphadenectomy has been the subject of several studies, and a consensus of opinion is starting to form to define indications and methods of identification concerning the use of this technique. At the Institut Curie since 1996, we have been using the Patenté blue dye technique and from 1998 we have used the combination of blue dye and technetium labeled sulfur colloid. This article summarizes the principales aspect of this technique.
authors.affiliation: Service de Chirurgie Générale et Sénologique (Dr K.B Clough).
authors.forename: C
authors.initials: C
authors.lastname: Nos
authors.forename: P
authors.initials: P
authors.lastname: Fréneaux
authors.forename: K B
authors.initials: KB
authors.lastname: Clough
mesh_terms: D001365:Axilla; D001706:Biopsy; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery; D004396:Coloring Agents; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology*; D011877:Radionuclide Imaging
chemical_list: D004396:Coloring Agents